scholarly journals A CASE OF AFFERENT LOOP OBSTRUCTION ASSOCIATED WITH REMNANT GASTRIC CANCER

2011 ◽  
Vol 72 (8) ◽  
pp. 2004-2008
Author(s):  
Takahiro TOYOKAWA ◽  
Yoshito YAMASHITA ◽  
Atsushi YAMAMOTO ◽  
Tohru INOUE ◽  
Teruyuki IKEHARA ◽  
...  
2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Shu Aoyama ◽  
Masaaki Motoori ◽  
Yasuhiro Miyazaki ◽  
Tomoki Sugimoto ◽  
Yujiro Nishizawa ◽  
...  

Abstract Background There are only few reported cases of remnant gastric cancer with concomitant afferent loop syndrome. Emergency surgery is the standard treatment strategy for this disease. However, some afferent loop syndrome cases, especially those with complete obstruction, can lead to a septic state, which makes performing emergency surgery risky. We describe a case of remnant gastric cancer with complete afferent loop obstruction, which was successfully managed by radical surgery following percutaneous transhepatic cholangial drainage of the afferent loop. Case presentation A 71-year-old man presented with nausea and abdominal discomfort. When he was 27 years old, he had undergone distal gastrectomy for a benign gastric ulcer, with gastrojejunostomy (Billroth II reconstruction). Abdominal computed tomography revealed thickening of the anastomosis site and significant dilation of the afferent loop. Gastrointestinal fiberscopy revealed advanced remnant gastric cancer at the anastomosis site, and the stoma of the afferent loop was completely obstructed. We diagnosed the patient with remnant gastric cancer with afferent loop syndrome. Percutaneous transhepatic cholangial drainage was performed twice before surgery to decompress the afferent loop. This provided more time for the patient to recover. Radical surgery of total remnant gastrectomy and Roux-en-Y reconstruction were performed electively. There were no severe postoperative complications. The patient died 8 months following the operation owing to peritoneal dissemination recurrence. Conclusion We encountered a case of remnant gastric cancer with afferent loop obstruction, which was successfully managed by radical surgery following decompression of the afferent loop by percutaneous transhepatic cholangial drainage. Percutaneous transhepatic cholangial drainage effectively managed the afferent loop syndrome, resulting in the safe performance of elective surgery.


2003 ◽  
Vol 28 (5) ◽  
pp. 624-630 ◽  
Author(s):  
H.-C. Kim ◽  
J. K. Han ◽  
K. W. Kim ◽  
Y. H. Kim ◽  
H.-K. Yang ◽  
...  

Author(s):  
Kazutoshi KOTANI ◽  
Yoshiki UMEMORI ◽  
Yasushi SATOH ◽  
Shigeki MAKIHARA

2015 ◽  
Vol 2015 ◽  
pp. 1-4
Author(s):  
Memduh şahin ◽  
Bahattin Ozlu ◽  
Kivilcim Eren Erdogan ◽  
Tahsin Colak

Remnant gastric cancer is a rare clinical entity. Herein we describe a patient with remnant gastric cancer that presented with afferent loop syndrome 47 years after Billroth II surgery. Symptoms of serious bilious vomiting were an indication to perform early endoscopic diagnosis, followed by complete gastric resection. In particular, patients that have undergone surgery due to benign indications should be examined endoscopically, even a long time after initial surgery.


2020 ◽  
Vol 53 (6) ◽  
pp. 481-486
Author(s):  
Kenta Katsumata ◽  
Takeharu Enomoto ◽  
Takehito Otsubo ◽  
Masaki Hiwatari ◽  
Yoshitsugu Tsukamoto ◽  
...  

Medicine ◽  
2018 ◽  
Vol 97 (50) ◽  
pp. e13072
Author(s):  
Ra Ri Cha ◽  
Su Beom Cho ◽  
Wan Soo Kim ◽  
Jin Joo Kim ◽  
Jae Min Lee ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Honghu Wang ◽  
Hao Qi ◽  
Xiaofang Liu ◽  
Ziming Gao ◽  
Iko Hidasa ◽  
...  

AbstractThe staging system of remnant gastric cancer (RGC) has not yet been established, with the current staging being based on the guidelines for primary gastric cancer. Often, surgeries for RGC fail to achieve the > 15 lymph nodes needed for TNM staging. Compared with the pN staging system, lymph node ratio (NR) may be more accurate for RGC staging and prognosis prediction. We retrospectively analyzed the data of 208 patients who underwent R0 gastrectomy with curative intent and who have ≤ 15 retrieved lymph nodes (RLNs) for RGC between 2000 and 2014. The patients were divided into four groups on the basis of the NR cutoffs: rN0: 0; rN1: > 0 and ≤ 1/6; rN2: > 1/6 and ≤ 1/2; and rN3: > 1/2. The 5-year overall survival (OS) rates for rN0, rN1, rN2, and rN3 were 84.3%, 64.7%, 31.5%, and 12.7%, respectively. Multivariable analyses revealed that tumor size (p = 0.005), lymphovascular invasion (p = 0.023), and NR (p < 0.001), but not pN stage (p = 0.682), were independent factors for OS. When the RLN count is ≤ 15, the NR is superior to pN as an important and independent prognostic index of RGC, thus predicting the prognosis of RGC patients more accurately.


Sign in / Sign up

Export Citation Format

Share Document